¼¼°èÀÇ ¾ËÆÄ¸®Æ÷»ê ½ÃÀå
Alpha-lipoic Acid
»óǰÄÚµå : 1784961
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 271 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,201,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,603,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀº 2030³â±îÁö 13¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 10¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀº 2024-2030³â¿¡ CAGR 4.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ R¥á ¸®Æ÷»êÀº CAGR 5.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 8¾ï 2,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. S¥á ¸®Æ÷»ê ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 7,360¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾ËÆÄ¸®Æ÷»ê½ÃÀåÀº 2024³â¿¡´Â 2¾ï 7,360¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 7.9%·Î, 2030³â±îÁö 2¾ï 6,690¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.3%¿Í 4.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾ËÆÄ¸®Æ÷»ê ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾ËÆÄ¸®Æ÷»êÀÌ °Ç°­, À£ºù, ÀǾàǰ¿¡¼­ ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

¾ËÆÄ¸®Æ÷»ê(ALA)Àº ÀÚ¿¬ÀûÀ¸·Î Á¸ÀçÇÏ´Â Ç×»êÈ­Á¦ÀÌÀÚ ´ë»ç º¸Á¶È¿¼ÒÀ̸ç, °­·ÂÇÑ Ç׿°Áõ, Ç׳ëÈ­, ½Å°æ º¸È£ ÀÛ¿ëÀ¸·Î °Ç°­, À£´Ï½º, Á¦¾à¾÷°è¿¡¼­ Å« ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. ½Ã±ÝÄ¡, ºê·ÎÄݸ®, ³»ÀåÀ° µîÀÇ ½Äǰ¿¡ ¼Ò·® ÇÔÀ¯µÇ¾î ÀÖ´Â ALA´Â ÀÎü ³»¿¡¼­µµ ÇÕ¼ºµÇ¾î ¿¡³ÊÁö ´ë»ç¿Í ¼¼Æ÷ º¹±¸¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Ȱ¼º»ê¼Ò¸¦ ÁßÈ­½Ã۰í, ´Ù¸¥ Ç×»êÈ­ ¹°Áú(ºñŸ¹Î C, ºñŸ¹Î E µî)À» Àç»ý½Ã۸ç, Àν¶¸° °¨¼ö¼ºÀ» Çâ»ó½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖÀ¸¸ç, ¿µ¾çº¸ÃæÁ¦, ÇǺι̿ë, Ä¡·áÁ¦·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù.

³ëÈ­ ¹æÁö ¹× ´ë»ç °Ç°­¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 °Ç°­À» Áß½ÃÇÏ´Â ¼ÒºñÀÚ¿Í ÀÇ·áÁø »çÀÌ¿¡¼­ ALAÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ALA´Â ¼ö¿ë¼º°ú Áö¿ë¼ºÀÇ µÎ °¡Áö ÀÛ¿ëÀ» ÇÏ´Â Ç×»êÈ­Á¦·Î¼­ »ýü ÀÌ¿ë·üÀÌ ¶Ù¾î³ª »êÈ­ ½ºÆ®·¹½º °¨¼Ò, ¹ÌÅäÄܵ帮¾Æ ±â´É °³¼±, ½Å°æ °Ç°­ À¯Áö¿¡ ¸Å¿ì È¿°úÀûÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡ ½Å°æÀå¾Ö Ä¡·á, üÁßÁ¶Àý º¸Á¶Á¦, ³ëÈ­¹æÁö-ÇǺι̿ëÁ¦ µî¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ 2Çü ´ç´¢º´, ½ÉÇ÷°ü °Ç°­, ½Å°æ ÅðÇ༺ Áúȯ °ü¸®¿¡¼­ ALAÀÇ ÀáÀç·ÂÀº ¿¬±¸¿Í ÀÓ»ó Àû¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸¿¡ µû¸£¸é ALA´Â Æ÷µµ´ç ´ë»ç¸¦ ÃËÁøÇϰí, ¿°ÁõÀ» ¾ïÁ¦Çϸç, »êÈ­Àû ¼Õ»óÀ¸·ÎºÎÅÍ ½Å°æ ¼¼Æ÷¸¦ º¸È£ÇÏ¿© ´ç´¢º´ °ü¸®, ¾ËÃ÷ÇÏÀ̸Ӻ´ ¿¹¹æ, ½ÉÇ÷°ü °Ç°­ º¸Á¶ ½ÄǰÀÇ À¯¸Á ¼ººÐÀ¸·Î ¹àÇôÁ³½À´Ï´Ù. °úÇÐÀû °ËÁõ°ú ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í¼øµµ ¹× »ýü ÀÌ¿ë·üÀÌ ³ôÀº ALA º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä µ¿ÇâÀº?

¾ËÆÄ¸®Æ÷»ê(ALA) ½ÃÀåÀº º¸ÃæÁ¦ Á¦Á¦ÀÇ ¹ßÀü, Àå¼ö ¿¬±¸¿¡ ´ëÇÑ °ü½É Áõ°¡, ´ë»ç¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ µ¿Çâ Áß Çϳª´Â ±â´É¼º ¿µ¾ç°ú ¹ÙÀÌ¿ÀÇØÅ·¿¡¼­ ALA¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¼ÒºñÀÚµéÀÌ Àå¼ö¸¦ À§ÇÑ º¸ÃæÁ¦¸¦ ã´Â °¡¿îµ¥ ALA´Â ¹ÌÅäÄܵ帮¾Æ ÃÖÀûÈ­Á¦·Î¼­ ¼¼Æ÷ÀÇ ¿¡³ÊÁö »ý»ê, ÀÎÁö ±â´É, Àü¹ÝÀûÀΠȰ·Â ÁõÁø¿¡ µµ¿òÀ» ÁÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁö¸é¼­ ÆÇ¸Å·®ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ALA´Â ³ëÈ­¹æÁö, ³ú Ȱ¼ºÈ­, ÇâÁ¤½Å¼º ÀǾàǰ µî ´Ù¾çÇÑ °Ç°­±â´É½Äǰ¿¡ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù.

¶Ç ´Ù¸¥ Áß¿äÇÑ Ãß¼¼´Â ALAÀÇ ÀǾàǰ ¹× Ä¡·á ÀÀ¿ë, ƯÈ÷ ´ç´¢º´¼º ½Å°æº´Áõ°ú ½ÉÇ÷°ü °Ç°­À¸·ÎÀÇ È®ÀåÀÔ´Ï´Ù. ALA´Â ´ç´¢º´ ȯÀÚÀÇ ½Å°æÅëÀ» ¿ÏÈ­Çϰí Ç÷¾×¼øÈ¯À» °³¼±ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µÀ¸¸ç, 󹿾à°ú ÀϹÝÀǾàǰ(OTC)ÀÇ ½Å°æÀå¾Ö Ä¡·áÁ¦·Îµµ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ALAÀÇ LDL ÄÝ·¹½ºÅ׷Ѱú »êÈ­ ½ºÆ®·¹½º¸¦ ³·Ãß´Â ´É·ÂÀº ½ÉÀå¿¡ ÁÁÀº º¸ÃæÁ¦·Î ÀÚ¸®¸Å±èÇÏ¿© ½ÉÇ÷°ü ¹× Ç÷´ç °ü¸® Á¦Á¦¿¡ ´ëÇÑ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ºÆ÷Ã÷ ¿µ¾ç ¹× üÁß °ü¸® ¾÷°è¿¡¼­µµ ALA¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹ÌÅäÄܵ帮¾Æ ±â´ÉÀ» Çâ»ó½ÃŰ°í ±ÙÀ°³» Æ÷µµ´ç Èí¼ö¸¦ Áõ°¡½ÃŰ´Â ¿ªÇÒÀ» ÇÏ´Â ALA´Â Áö¹æ ¿¬¼Ò ¹× Áö±¸·Â Çâ»ó¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Â º¸ÃæÁ¦·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸¹Àº ¿îµ¿¼±¼ö¿Í ÇÇÆ®´Ï½º ¾ÖÈ£°¡µéÀº ALA¸¦ ±ÙÀ° ȸº¹°ú ¿¡³ÊÁö ·¹º§À» ³ôÀ̴ õ¿¬ ´ë»ç ÃËÁøÁ¦·Î ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ALA¸¦ ¾Æ¼¼Æ¿-L-Ä«¸£´Ïƾ(ALCAR) ¹× CoQ10°ú °áÇÕÇÏ¿© ¼º´É¿¡ ÁßÁ¡À» µÐ Ç×ÇÇ·Î º¸ÃæÁ¦ ½ºÅÃÀ¸·Î Àαâ ÀÖ´Â Àü·«ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

½ºÅ²ÄÉ¾î ¾÷°è¿¡¼­´Â Ç×»êÈ­ ¹°ÁúÀÌ Ç³ºÎÇÑ ¾ÈƼ¿¡ÀÌ¡ Á¦Á¦ÀÇ µîÀåÀ¸·Î ALA°¡ ¼¼·³, Å©¸², °æ±¸¿ë ¹Ì¿ë º¸Á¶Á¦ µî¿¡ Ȱ¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ALA´Â Äݶó°Õ À¯Áö, ¹Ì¹é, Ç׿°Áõ ÀÛ¿ëÀÌ ÀÖÀ¸¸ç, ÀÜÁÖ¸§, »ö¼ÒÄ§Âø, »êÈ­ ¼Õ»óÀ» Ÿ°ÙÀ¸·Î ÇÑ È­Àåǰ¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ºñŸ¹Î C ¹× ±Û·çŸġ¿Â°ú ½Ã³ÊÁö È¿°ú¸¦ ¹ßÈÖÇÏ´Â µ¶Æ¯ÇÑ ´É·ÂÀº ALA¸¦ °í±Þ ÇǺΠȸº¹ ¹× ȸÃá Á¦Á¦ÀÇ ÁÖ¿ä ¼ººÐÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

¾ËÆÄ¸®Æ÷»ê ¼ö¿ä¸¦ ÁÖµµÇÏ´Â »ê¾÷Àº?

°Ç°­ º¸Á¶ ½Äǰ ¹× ¿µ¾ç º¸Á¶ ½Äǰ »ê¾÷Àº ALAÀÇ °¡Àå Å« ¼ÒºñÀÚ·Î ÀÏ¹Ý °Ç°­, ³ëÈ­ ¹æÁö ¹× ½ÅÁø ´ë»ç °Ç°­ Á¦Á¦¿¡ ÅëÇյǾî ÀÖ½À´Ï´Ù. ¸¹Àº º¸ÃæÁ¦ ºê·£µå´Â ALAÀÇ Ç×»êÈ­ ´É·Â, Àν¶¸° °¨¼ö¼º °³¼±, ½Å°æ °Ç°­ Áö¿ø, Ç÷´ç Á¶Àý, üÁß °ü¸®, ÇØµ¶ Á¦Ç°ÀÇ Çʼö ¼ººÐÀ¸·Î È«º¸Çϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¿µ¾ç ¼·Ãë¿Í Àå¼ö¿¡ ÃÊÁ¡À» ¸ÂÃá °Ç°­±â´É½ÄǰÀÇ µîÀåÀ¸·Î »ýü ÀÌ¿ë·üÀÌ ³ôÀº ALA Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Á¦¾à ¹× ÀÇ·á ºÐ¾ßµµ ALA ½ÃÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ALA´Â ½Å°æÀå¾Ö Ä¡·á¿Í ´ç´¢º´ °ü¸®¿¡ ´ëÇÑ °­·ÂÇÑ ÀÓ»óÀû ±Ù°Å¸¦ ¹ÙÅÁÀ¸·Î ½Å°æ°è ¹× ½ÉÇ÷°ü°è ÀǾàǰ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀº ½Å°æÅë ¿ÏÈ­, »êÈ­ ½ºÆ®·¹½º °ü·Ã Áúº´ ÅðÄ¡, ¹ÌÅäÄܵ帮¾Æ °Ç°­À» Áö¿øÇÏ´Â ALA ±â¹Ý 󹿾àÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ´Ù¹ß¼º °æÈ­Áõ µîÀÇ Áõ»ó¿¡¼­ ALAÀÇ ½Å°æ º¸È£ È¿°ú¿¡ ´ëÇÑ ¿¬±¸µµ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

½ºÆ÷Ã÷ ¿µ¾ç ¹× ÇÇÆ®´Ï½º »ê¾÷Àº ALA°¡ ¿îµ¿ Àü, ÇǷΠȸº¹ ¹× ½ÅÁø´ë»ç ÃËÁø º¸ÃæÁ¦¿¡ Æ÷ÇԵǸ鼭 ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ALA°¡ ¿¡³ÊÁö »ý»ê, ±ÙÀ° ȸº¹, Àν¶¸° Á¶Àý¿¡ ¹ÌÄ¡´Â ¿ªÇÒ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿îµ¿¼±¼ö¿Í ÇÇÆ®´Ï½º ¾ÖÈ£°¡¸¦ À§ÇÑ ¼º´É Çâ»ó ¹× Áö¹æ °¨¼Ò º¸ÃæÁ¦¿¡ ALA°¡ äÅõǰí ÀÖ½À´Ï´Ù.

È­Àåǰ ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷µµ ƯÈ÷ ³ëÈ­ ¹æÁö ¹× Ç×»êÈ­ ½ºÅ²ÄÉ¾î ºÐ¾ß ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿Ü¿ë ¹× ¼·Ãë °¡´ÉÇÑ ¹Ì¿ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ALA´Â ÁÖ¸§ °³¼± ¼¼·³, ¹Ì¹é Å©¸², °æ±¸¿ë ¹Ì¿ë º¸Á¶Á¦ µî¿¡ ÇÔÀ¯µÇ¾î ÀÖ½À´Ï´Ù. ȯ°æ ¿À¿° ¹°ÁúÀ» ÁßÈ­½Ã۰í, ÇÞºµ¿¡ ÀÇÇÑ ¼Õ»óÀ» º¹±¸Çϸç, Äݶó°Õ ÇÕ¼ºÀ» ÃËÁøÇÏ´Â ALAÀÇ ´É·ÂÀº °í±Þ ½ºÅ²ÄÉ¾î ºê·£µå¿Í ÇǺΰú ÀÇ»çµéÀÌ ±ÇÀåÇÏ´Â Æ÷¹Ä·¯¿¡¼­ ¸Å¿ì Àαâ ÀÖ´Â ¼ººÐÀ¸·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù.

¼¼°è ¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀÇ ¼ºÀåÀº Ç×»êÈ­ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀÎ½Ä Áõ°¡, ´ë»ç¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀǾàǰ ¹× È­Àåǰ¿¡ ´ëÇÑ Àû¿ë È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â Àå¼ö¿Í ¹ÌÅäÄܵ帮¾Æ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. °í·ÉÈ­ »çȸ°¡ ³ëÈ­ ¹æÁö ¹× ¿¡³ÊÁö °­È­ ¼Ö·ç¼ÇÀ» ã´Â °¡¿îµ¥, ALA´Â ¼¼Æ÷ º¹±¸, ÀÎÁö ±â´É ¹× Àü¹ÝÀûÀΠȰ·ÂÀ» Áö¿øÇÏ´Â Áß¿äÇÑ ¹ÙÀÌ¿ÀÇØÅ· º¸ÃæÁ¦·Î Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

´ç´¢º´°ú ½Å°æÀå¾Ö Áõ°¡µµ ALA ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â Å« ¿äÀÎÀÔ´Ï´Ù. Àü ¼¼°è¿¡¼­ ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µéÀÌ ´ç´¢º´°ú °ü·ÃµÈ ½Å°æ Àå¾Ö·Î °íÅë ¹Þ°í ÀÖ´Â °¡¿îµ¥, ALA´Â ½Å°æ º¸È£ ¹× Ç÷´ç Á¶Àý È¿°ú·Î ÀÎÇØ ÀÇ»ç¿Í ¿µ¾çÇÐÀÚµéÀÌ ³Î¸® ±ÇÀåÇϰí ÀÖ½À´Ï´Ù. Ç׿°Áõ ÀÛ¿ë°ú Àν¶¸° ±â´ÉÀ» °³¼±ÇÏ´Â ´É·ÂÀº ±âÁ¸ÀÇ ´ç´¢º´ Ä¡·áÁ¦¸¦ ´ëüÇÒ ¼ö ÀÖ´Â ¸Å·ÂÀûÀΠõ¿¬ ¼ººÐÀ¸·Î °¢±¤¹Þ°í ÀÖ½À´Ï´Ù.

ALAÀÇ Á¦ÇüÈ­ ¹× »ýü ÀÌ¿ë·üÀÇ ±â¼úÀû Áøº¸µµ ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸®Æ÷Á» ¹× ¼­¹æÇü ALA º¸ÃæÁ¦´Â Èí¼ö¸¦ °³¼±Çϰí È¿°ú¸¦ Áö¼Ó½Ã۱â À§ÇØ °³¹ßµÇ¾î °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚ¿¡°Ô ´õ¿í ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ALA¿Í ±Û·çŸġ¿Â, CoQ10, ·¹½ºº£¶óÆ®·Ñ°ú °°Àº ½Ã³ÊÁö È¿°ú°¡ ÀÖ´Â Ç×»êÈ­Á¦¸¦ °áÇÕÇÏ¿© Â÷¼¼´ë Ç׳ëÈ­ ¹× ½Å°æ º¸È£ º¸ÃæÁ¦¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù.

E-Commerce¿Í D2C(Direct-to-Consumer, D2C) °Ç°­ ºê·£µåÀÇ È®´ë·Î ½ÃÀå µµ´Þ ¹üÀ§°¡ Å©°Ô È®´ëµÇ¾ú½À´Ï´Ù. ÇöÀç ¸¹Àº º¸ÃæÁ¦ ȸ»çµéÀÌ ¿Â¶óÀÎ Ç÷§ÆûÀ» ÅëÇØ ALA ±â¹Ý Á¦Á¦¸¦ ÆÇ¸ÅÇϰí ÀÖÀ¸¸ç, À̸¦ ÅëÇØ Àü ¼¼°è Á¢±Ù¼º°ú °³ÀÎÈ­µÈ º¸ÃæÁ¦ ÃßõÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ƯÈ÷ ¹ÙÀÌ¿À ÇØÄ¿, ÇÇÆ®´Ï½º ¾ÖÈ£°¡, Àå¼ö¿Í °Ç°­ ÁõÁøÀ» À§ÇÑ ÀÚ¿¬Àû ÇØ°áÃ¥À» ã´Â ³ë³âÃþ »çÀÌ¿¡¼­ ¼ÒºñÀÚ Ã¤Å÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ALAÀÇ °Ç°­ È¿°ú¸¦ Áö¿øÇÏ´Â Áö¼ÓÀûÀÎ ¿¬±¸, ´ë»ç ¹× ½Å°æ º¸È£ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÇǺΠ°ü¸® ¹× ÀǾàǰ¿¡ ´ëÇÑ ¾ÖÇø®ÄÉÀÌ¼Ç È®´ë·Î ÀÎÇØ ¼¼°è ¾ËÆÄ¸®Æ÷»ê ½ÃÀåÀº ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(R¥á ¸®Æ÷»ê, S¥á ¸®Æ÷»ê), ¿ëµµ(½ÄÀ̺¸ÃæÁ¦ ¿ëµµ, È­Àåǰ ¿ëµµ, ÀǾàǰ ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Alpha-lipoic Acid Market to Reach US$1.3 Billion by 2030

The global market for Alpha-lipoic Acid estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. R Alpha Lipoic Acid, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$823.1 Million by the end of the analysis period. Growth in the S Alpha Lipoic Acid segment is estimated at 3.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$273.6 Million While China is Forecast to Grow at 7.9% CAGR

The Alpha-lipoic Acid market in the U.S. is estimated at US$273.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$266.9 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Alpha-Lipoic Acid Market - Key Trends & Drivers Summarized

Why Is Alpha-Lipoic Acid Gaining Prominence in Health, Wellness, and Pharmaceuticals?

Alpha-lipoic acid (ALA), a naturally occurring antioxidant and metabolic coenzyme, has gained significant traction in the health, wellness, and pharmaceutical industries due to its powerful anti-inflammatory, anti-aging, and neuroprotective properties. Found in small amounts in foods such as spinach, broccoli, and organ meats, ALA is also synthesized in the human body and plays a crucial role in energy metabolism and cellular repair. Its ability to neutralize free radicals, regenerate other antioxidants (such as vitamin C and vitamin E), and improve insulin sensitivity has made it a sought-after ingredient in dietary supplements, skincare, and therapeutic applications.

The growing demand for anti-aging and metabolic health solutions has propelled ALA’s popularity among health-conscious consumers and medical professionals alike. As a dual-action antioxidant-meaning it is both water-soluble and fat-soluble-ALA offers superior bioavailability, making it highly effective in reducing oxidative stress, improving mitochondrial function, and supporting nerve health. This has led to its widespread use in neuropathy treatments, weight management supplements, and anti-aging skincare formulations.

Furthermore, ALA’s potential in managing type 2 diabetes, cardiovascular health, and neurodegenerative disorders has driven research and clinical applications. Studies indicate that ALA enhances glucose metabolism, reduces inflammation, and protects neurons from oxidative damage, making it a promising ingredient in diabetes management, Alzheimer’s prevention, and cardiovascular health supplements. With increasing scientific validation and consumer awareness, the demand for high-purity, bioavailable ALA supplements continues to grow.

What Are the Key Trends Driving the Alpha-Lipoic Acid Market?

The Alpha-Lipoic Acid (ALA) market is evolving rapidly due to advancements in supplement formulation, rising interest in longevity research, and the increasing prevalence of metabolic disorders. One of the most notable trends shaping the market is the growing demand for ALA in functional nutrition and biohacking. As consumers seek longevity-enhancing supplements, ALA is increasingly being marketed as a mitochondrial optimizer, helping to improve cellular energy production, cognitive function, and overall vitality. This has led to its integration into anti-aging, brain-boosting, and nootropic supplement blends.

Another key trend is the expansion of ALA into pharmaceutical and therapeutic applications, particularly in diabetic neuropathy and cardiovascular health. ALA has been shown to reduce nerve pain and improve circulation in diabetic patients, leading to its inclusion in prescription and over-the-counter (OTC) neuropathy treatments. Additionally, ALA’s ability to lower LDL cholesterol and oxidative stress has positioned it as a heart-healthy supplement, increasing its adoption in cardiovascular and blood sugar management formulations.

The sports nutrition and weight management industries are also driving increased interest in ALA. With its role in boosting mitochondrial function and increasing glucose uptake into muscles, ALA is being incorporated into fat-burning and endurance-enhancing supplements. Many athletes and fitness enthusiasts are turning to ALA as a natural metabolism booster that enhances muscle recovery and energy levels. Additionally, combining ALA with acetyl-L-carnitine (ALCAR) and CoQ10 has become a popular strategy in performance-focused and anti-fatigue supplement stacks.

In the skincare industry, the rise of antioxidant-rich anti-aging formulations has led to the increased use of ALA in serums, creams, and oral beauty supplements. Due to its collagen-preserving, skin-brightening, and anti-inflammatory effects, ALA is frequently used in cosmeceuticals targeting fine lines, hyperpigmentation, and oxidative damage. Its unique ability to work synergistically with vitamin C and glutathione has positioned ALA as a key ingredient in advanced skin repair and rejuvenation formulations.

Which Industries Are Driving the Demand for Alpha-Lipoic Acid?

The dietary supplements and nutraceutical industry remains the largest consumer of ALA, incorporating it into general wellness, anti-aging, and metabolic health formulations. Many supplement brands promote ALA for its antioxidant capabilities, insulin sensitivity improvement, and nerve health support, making it a staple ingredient in blood sugar control, weight management, and detoxification products. The rise of personalized nutrition and longevity-focused supplements has further boosted demand for high-bioavailability ALA formulations.

The pharmaceutical and medical sectors are also significant contributors to the ALA market. With strong clinical backing in neuropathy treatment and diabetes management, ALA is widely used in neurological and cardiovascular drugs. Pharmaceutical companies are developing ALA-based prescription medications to reduce nerve pain, combat oxidative stress-related diseases, and support mitochondrial health. Research is also ongoing into ALA’s neuroprotective effects in conditions like Alzheimer’s, Parkinson’s, and multiple sclerosis.

The sports nutrition and fitness industry is another key driver, as ALA is being incorporated into pre-workout, recovery, and metabolism-enhancing supplements. The increasing awareness of ALA’s role in energy production, muscle recovery, and insulin regulation has led to its adoption in performance-enhancing and fat-loss supplements aimed at athletes and fitness enthusiasts.

The cosmetics and personal care industry is also fueling demand, particularly in the anti-aging and antioxidant skincare segments. With growing consumer interest in topical and ingestible beauty solutions, ALA is featured in anti-wrinkle serums, brightening creams, and oral beauty supplements. Its ability to neutralize environmental pollutants, repair sun damage, and boost collagen synthesis makes it a highly sought-after ingredient in premium skincare brands and dermatologist-recommended formulations.

What Is Driving the Growth of the Global Alpha-Lipoic Acid Market?

The growth in the alpha-lipoic acid market is driven by several factors, including rising consumer awareness of antioxidant supplementation, increasing prevalence of metabolic disorders, and expanding applications in pharmaceuticals and cosmetics. One of the key drivers is the growing focus on longevity and mitochondrial health. With aging populations seeking anti-aging and energy-enhancing solutions, ALA has gained popularity as a key biohacking supplement that supports cellular repair, cognitive function, and overall vitality.

The rising incidence of diabetes and neuropathy is another major factor fueling ALA demand. With millions of people worldwide suffering from diabetes-related nerve damage, ALA is being widely recommended by doctors and nutritionists for its nerve-protective and blood sugar-regulating properties. Its anti-inflammatory effects and ability to improve insulin function make it an attractive natural alternative to traditional diabetes medications.

Technological advancements in ALA formulation and bioavailability have also played a crucial role in market expansion. Liposomal and sustained-release ALA supplements have been developed to improve absorption and prolong effectiveness, making them more appealing to health-conscious consumers. Additionally, the combination of ALA with synergistic antioxidants like glutathione, CoQ10, and resveratrol has led to the development of next-generation anti-aging and neuroprotective supplements.

The expansion of e-commerce and direct-to-consumer (DTC) health brands has significantly increased market reach. Many supplement companies now market ALA-based formulations through online platforms, enabling global accessibility and personalized supplement recommendations. This has led to higher consumer adoption rates, particularly among biohackers, fitness enthusiasts, and aging populations looking for natural solutions to enhance longevity and well-being.

With continuous research supporting ALA’s health benefits, increasing demand for metabolic and neuroprotective supplements, and expanding applications in skincare and pharmaceuticals, the global alpha-lipoic acid market is poised for strong growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Alpha-lipoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (R Alpha Lipoic Acid, S Alpha Lipoic Acid); Application (Dietary Supplements Application, Cosmetics Application, Pharmaceuticals Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â